Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament composition with function for reducing blood sugar

A technology for lowering blood sugar and composition, which is applied in the field of compositions containing guava leaf extract and rosiglitazone or pioglitazone, which can solve the problems of slow onset of action and achieve the effect of reducing side effects

Inactive Publication Date: 2009-01-21
刘全胜
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, when traditional Chinese medicine is used alone, although it has a good hypoglycemic effect, it has the disadvantage of slow onset and needs to be dialectically used under the guidance of experienced Chinese medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament composition with function for reducing blood sugar
  • Medicament composition with function for reducing blood sugar

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1 capsule preparation

[0027] Its components and content are:

[0028] Guava Leaf Extract 300mg

[0029] Rosiglitazone 1mg

[0030] Excipients Appropriate amount

[0031] The auxiliary material is water-soluble starch, which can be made into capsules according to the conventional capsule technology.

Embodiment 2

[0032] Embodiment 2 common sheet preparation

[0033] Its components and content are:

[0034] Guava Leaf Extract 300mg

[0035] Rosiglitazone 2mg

[0036] Excipients Appropriate amount

[0037] The auxiliary materials are microcrystalline cellulose (MCC), etc., which can be made into tablets of required specifications according to conventional tablet technology.

Embodiment 3

[0038] Embodiment 3 enteric-coated tablet preparation

[0039] Its components and content are:

[0040] Guava Leaf Extract 300mg

[0041] Rosiglitazone 4mg

[0042] Excipients Appropriate amount

[0043] The auxiliary materials are hydroxypropylmethylcellulose (HPMC), etc., which are made into tablets (tablet cores) of required specifications according to conventional tablet technology, and then wrapped with enteric coating.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug combination which can lower blood sugar, containing guava leaf extract and rosiglitazone or pioglitazone. The drug combination of the invention can not only put the sugar lowering function of guava leaf extract and rosiglitazone or pioglitazone into fullplay so as to lead to the synergetic effect of the two medicines, but also can reduce adverse reaction and give full play to the advantages of definite curative effect and rapid onset time of chemical drugs as well as the functions of balancing the human body and lowering toxicity of traditional Chinese medicines.

Description

technical field [0001] The invention relates to a Chinese and Western medicine composition for treating diabetes, specifically a composition comprising guava leaf extract and rosiglitazone or pioglitazone, belonging to the technical field of medicines. Background technique [0002] Diabetes has become a worldwide problem. There are currently 180 million people with diabetes worldwide, and that number is expected to double to 360 million by 2030. In China, according to the 2007 Chinese Diabetes Society Symposium, the number of patients has reached 39.8 million, and it is expected that this number will exceed 59.3 million by 2025. The latest data from the International Diabetes Federation (IDF) shows that in 2007, about 3.8 million people died of diabetes worldwide, which is four times the number of deaths from malaria and equivalent to the number of deaths from AIDS. [0003] According to the report of the World Health Organization, diabetic patients in developing countries...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/61A61P3/10A61K31/4439A61K127/00
Inventor 刘全胜曹俊伍曾利马明
Owner 刘全胜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com